140 related articles for article (PubMed ID: 26355708)
1. Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.
Braulke F; Müller-Thomas C; Götze K; Platzbecker U; Germing U; Hofmann WK; Giagounidis AA; Lübbert M; Greenberg PL; Bennett JM; Solé F; Slovak ML; Ohyashiki K; Le Beau MM; Tüchler H; Pfeilstöcker M; Hildebrandt B; Aul C; Stauder R; Valent P; Fonatsch C; Bacher U; Trümper L; Haase D; Schanz J
Genes Chromosomes Cancer; 2015 Dec; 54(12):809-17. PubMed ID: 26355708
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic monitoring from CD34+ peripheral blood cells in myelodysplastic syndromes: first results from a prospective multicenter German diagnostic study.
Braulke F; Jung K; Schanz J; Götze K; Müller-Thomas C; Platzbecker U; Germing U; Brümmendorf TH; Bug G; Ottmann O; Giagounidis AA; Stadler M; Hofmann WK; Schafhausen P; Lübbert M; Schlenk RF; Blau IW; Ganster C; Pfeiffer S; Shirneshan K; Metz M; Detken S; Seraphin J; Jentsch-Ullrich K; Böhme A; Schmidt B; Trümper L; Haase D
Leuk Res; 2013 Aug; 37(8):900-6. PubMed ID: 23623559
[TBL] [Abstract][Full Text] [Related]
3. Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.
Braulke F; Platzbecker U; Müller-Thomas C; Götze K; Germing U; Brümmendorf TH; Nolte F; Hofmann WK; Giagounidis AA; Lübbert M; Greenberg PL; Bennett JM; Solé F; Mallo M; Slovak ML; Ohyashiki K; Le Beau MM; Tüchler H; Pfeilstöcker M; Nösslinger T; Hildebrandt B; Shirneshan K; Aul C; Stauder R; Sperr WR; Valent P; Fonatsch C; Trümper L; Haase D; Schanz J
Haematologica; 2015 Feb; 100(2):205-13. PubMed ID: 25344522
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
Braulke F; Schulz X; Germing U; Schuler E; Platzbecker U; Nolte F; Hofmann WK; Giagounidis A; Götze K; Lübbert M; Schlenk RF; Schanz J; Bacher U; Ganser A; Büsche G; Letsch A; Schafhausen P; Bug G; Brümmendorf TH; Haas R; Trümper L; Shirneshan K; Haase D
Ann Hematol; 2017 Jun; 96(6):887-894. PubMed ID: 28374162
[TBL] [Abstract][Full Text] [Related]
5. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
[TBL] [Abstract][Full Text] [Related]
7. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events.
Tang Z; Li Y; Wang W; Yin CC; Tang G; Aung PP; Hu S; Lu X; Toruner GA; Medeiros LJ; Khoury JD
Leuk Res; 2018 Oct; 73():86-94. PubMed ID: 30248580
[TBL] [Abstract][Full Text] [Related]
8. Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities.
Andreasson P; Johansson B; Arheden K; Billström R; Mitelman F; Höglund M
Genes Chromosomes Cancer; 1997 Jun; 19(2):77-83. PubMed ID: 9171997
[TBL] [Abstract][Full Text] [Related]
9. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
10. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.
Sato Y; Suto Y; Pietenpol J; Golub TR; Gilliland DG; Davis EM; Le Beau MM; Roberts JM; Vogelstein B; Rowley JD
Blood; 1995 Aug; 86(4):1525-33. PubMed ID: 7632960
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
[TBL] [Abstract][Full Text] [Related]
12. FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: verification of the method and application to 27 MDS patients.
Braulke F; Schanz J; Jung K; Shirneshan K; Schulte K; Schuetze C; Steffens R; Trümper L; Haase D
Leuk Res; 2010 Oct; 34(10):1296-301. PubMed ID: 20226527
[TBL] [Abstract][Full Text] [Related]
13. Interstitial deletion of the short arm of chromosome 12 during clonal evolution in myelodysplastic syndrome with t(5;12)(q13;p13) involving the ETV6 gene.
Yamamoto K; Nagata K; Yagasaki F; Tsurukubo Y; Tamura A; Taniwaki M; Hamaguchi H
Cancer Genet Cytogenet; 2000 Jun; 119(2):113-7. PubMed ID: 10867145
[TBL] [Abstract][Full Text] [Related]
14. Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12.
Streubel B; Sauerland C; Heil G; Freund M; Bartels H; Lengfelder E; Wandt H; Ludwig WD; Nowotny H; Baldus M; Grothaus-Pinke B; Büchner T; Fonatsch C
Br J Haematol; 1998 Mar; 100(3):521-33. PubMed ID: 9504635
[TBL] [Abstract][Full Text] [Related]
15. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies.
Wlodarska I; Marynen P; La Starza R; Mecucci C; Van den Berghe H
Cytogenet Cell Genet; 1996; 72(2-3):229-35. PubMed ID: 8978784
[TBL] [Abstract][Full Text] [Related]
16. [Analysis and clinical significance of ETV6 rearrangement in myelodysplastic syndromes patients].
Ding BT; Guo NJ; Sun JZ; Gao HM; Wang YS; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2007 Dec; 28(12):804-7. PubMed ID: 18476590
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
Pitchford CW; Hettinga AC; Reichard KK
Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
[TBL] [Abstract][Full Text] [Related]
18. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
[TBL] [Abstract][Full Text] [Related]
20. Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact.
Bacher U; Haferlach T; Schnittger S; Zenger M; Meggendorfer M; Jeromin S; Roller A; Grossmann V; Krauth MT; Alpermann T; Kern W; Haferlach C
Br J Haematol; 2014 Mar; 164(6):822-33. PubMed ID: 24372512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]